How Often Do You Have to Take Wegovy®: A Guide to Its Weekly Dosing Schedule

Last reviewed: July 3, 2026

Last updated: July 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy and similar GLP-1 receptor agonists use a once-weekly injection schedule designed to provide steady appetite suppression throughout the seven-day cycle. Unlike daily oral medications, this weekly cadence reduces injection frequency while maintaining consistent blood levels of the active compound. Understanding your injection timing and dose progression helps maximize results while managing expectations about the treatment timeline.

Weekly Injection Timing: Your Semaglutide Schedule

Semaglutide injections work best when administered on the same day each week, creating a predictable rhythm that your body adapts to over time. You can choose Monday, Wednesday, Friday, or any other preferred day—consistency matters more than the specific calendar date. Most patients set a phone reminder to inject at the same time each week, which also helps track whether side effects occur predictably after injection or fade as your body adjusts.

The medication reaches peak concentration in your bloodstream 24 to 72 hours after injection, which is why appetite suppression typically becomes noticeable within one to three days of your weekly dose. Some patients report feeling maximum hunger reduction by day three or four, then noticing gradual return of appetite by day six or seven, just before their next scheduled injection. This natural rhythm allows your body to have brief periods of normal hunger signals while maintaining overall caloric deficit.

Dose Escalation Protocol: From 0.25mg to Maintenance

The standard titration schedule starts at 0.25 milligrams per week for the first four weeks, then increases by 0.25-milligram increments every four weeks until reaching your target dose, typically 2.4 milligrams weekly. This gradual step-up approach gives your digestive system time to adapt to the medication's effects, significantly reducing nausea and other gastrointestinal symptoms that occur with faster dose increases. Most patients tolerate the progression well and complete the full 16-week escalation phase without discontinuing treatment.

Your dose advancement depends on how well you're tolerating the current level and your weight loss progress, not a fixed calendar. If gastrointestinal side effects become bothersome at any step, your healthcare provider can extend that dose phase for an extra four weeks before advancing. Conversely, if you're tolerating a dose without significant side effects and experiencing good appetite suppression, moving forward on schedule supports faster achievement of your weight loss goals.

Maintenance Dosing and Long-Term Weekly Injections

Once you reach your maintenance dose—commonly 1.7 or 2.4 milligrams weekly—you continue that same injection dose indefinitely as long as the medication remains effective and well-tolerated. Most patients maintain their maintenance dose for six months to several years, adjusting only if they experience new side effects or if their weight loss results plateau significantly. Continuing weekly injections at your target dose preserves the appetite-suppressing benefits that support sustained weight management.

Some patients ask whether they can skip weeks or inject every two weeks to reduce medication costs, but this approach undermines the medication's effectiveness because semaglutide requires consistent weekly dosing to maintain therapeutic blood levels. Missing a single weekly injection may allow appetite to return and caloric intake to increase, potentially undoing several weeks of progress. PlexusDx's flat monthly pricing—at $189/mo month-to-month, or from $149/mo on the 6-month plan for compounded semaglutide—removes the financial incentive to skip doses, since your cost stays the same regardless of your dose level.

Compounded vs. Brand-Name Semaglutide Injection Schedules

Compounded semaglutide from licensed 503A pharmacies follows the identical once-weekly injection schedule as brand-name Wegovy, because both contain the same active pharmaceutical ingredient and require the same body absorption pattern to work effectively. The key difference lies in cost and access: PlexusDx compounded semaglutide is $189/mo month-to-month, or from $149/mo on the 6-month plan with flexible dosing options, while brand-name versions typically cost $900 to $1,300 per month and require insurance approval or cash payment at retail prices.

Both formulations use the same needle-and-pen injection devices, and both require storage in the refrigerator between 36°F and 46°F until first use, then at room temperature up to 86°F for 30 days once opened. Compounded versions from PlexusDx serve all 50 states without requiring insurance, membership fees, or prior authorization delays—you simply choose your dosing tier and start your weekly injection schedule immediately. Your injection technique, frequency, and dose progression remain identical whether you choose brand-name or compounded semaglutide.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I take my semaglutide injection on different days each week?

No — the Precision Peptide Genetic Test does not predict your response to Wegovy or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

What happens if I miss a weekly semaglutide injection?

If you miss your injection by one to two days, take it as soon as you remember, then resume your regular weekly schedule from that new date. Missing multiple weekly doses allows blood levels to drop, reducing appetite suppression and typically resulting in increased hunger and caloric intake within days. Consistent weekly dosing is essential for sustained weight loss.

How long does the appetite suppression last after a weekly injection?

Most patients experience maximum appetite suppression two to four days after injection, with noticeable hunger reduction continuing through day five or six, then gradually returning by day seven as medication levels decline. This rhythm is normal and expected, making the weekly schedule an effective way to maintain consistent appetite control while minimizing injection frequency.

Do I pay more if my dose increases from 0.25mg to 2.4mg per week?

No. PlexusDx compounded semaglutide injections cost a flat $189/mo (or $149/mo on the 6-month plan) regardless of your dose level, meaning your price stays the same whether you're taking 0.25 milligrams or 2.4 milligrams weekly. This transparent pricing removes barriers to reaching your optimal therapeutic dose.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

The Precision Peptide Genetic Test examines 14 metabolic pathways and 150+ genetic insights including GLP1R variants that influence semaglutide sensitivity, helping PlexusDx personalize your dosing strategy from the start. Testing is $298 and can identify whether you might need faster dose advancement or extended time at each step of your titration schedule.

Related Reading

• Wegovy Providers That Take Fsa Plexusdx
• Tirzepatide Dosing Schedule Plexusdx
• Do You Often Experience Unexplained Bloating Fatigue And Digestive Issues
• Ro Wegovy

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.